Australian Statistics on Medicines 2010

Table 1 - Antineoplastic And Immunomodulating Agents

L01 - ANTINEOPLASTIC AGENTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
ALKYLATING AGENTS
NITROGEN MUSTARD ANALOGUES
L01AA02 CHLORAMBUCIL
P 1163F Tablet 2mg — — 3,546 429,550
L01AA01 CYCLOPHOSPHAMIDE
P 1031G Injection 2g (solvent required) — — 11,708 631,658
P 1079T Injection 500mg (solvent required) — — 3,599 133,945
P 1080W Injection 1g (solvent required) — — 5,626 187,203
P 1266P Tablet 50mg — — 9,362 282,409
P 5914G Injection 500mg (solvent required) — — 3,450 51,419
P 5915H Injection 1g (solvent required) — — 5,589 112,853
P 5916J Injection 2g (solvent required) — — 1,897 77,146
P 6704W Injection 500 mg 10mL and NS — — 922 44,417
P 6710E Injection 1g 10mL and NS — — 1,830 69,731
P 7055H Injection 2g 10mL and NS — — 991 62,002
L01AA06 IFOSFAMIDE
P 5943T Powder for I.V. injection 1g — — 435 79,623
P 5944W Powder for I.V. injection 2g — — 219 78,345
P 8076C Powder for I.V. injection 1g — — 345 112,447
P 8077D Powder for I.V. injection 2g — — 1,022 628,368
L01AA03 MELPHALAN
P 2547C Tablet 2mg — — 3,078 150,417
ALKYL SULPHONATES
L01AB01 BUSULPHAN
P 1128J Tablet 2mg — — 482 41,061
NITROSOUREAS
L01AD05 FOTEMUSTINE
P 5900M Powder for injection 208mg with solvent — — 397 407,793
P 8786K Powder for injection 208mg with solvent — — 697 995,703
OTHER ALKYLATING AGENTS
L01AX03 TEMOZOLOMIDE
P 8378Y Capsule 5mg — — 289 79,652
P 8379B Capsule 20mg 5 — — 1,292 849,175
P 8380C Capsule 100mg 5 — — 4,698 11,437,106
P 8381D Capsule 250mg 5 — — 1,483 2,838,972
P 8819E Capsule 5mg 15 — — 386 131,428
P 8820F Capsule 20mg 15 — — 423 287,269
P 8821G Capsule 100mg 15 — — 539 1,375,070
P 9361Q Capsule 140mg 15 — — 1,131 4,033,033
P 9362R Capsule 140mg 5 — — 1,391 3,393,276
ANTIMETABOLITES
FOLIC ACID ANALOGUES
L01BA01 METHOTREXATE
P 1622J Tablet 2.5mg — — 66,905 887,923

L01 - ANTINEOPLASTIC AGENTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
ANTIMETABOLITES
P 1623K Tablet 10mg — — 111,764 5,128,258
P 2272N Tablet 10mg 15 — — 24,859 551,852
P 2395C Injection 50mg in 2mL — — 17,464 633,552
P 2396D Injection 5mg in 2mL — — 1,729 126,315
P 5875F Solution concentrate I.V. infusion 1000mg in 10mL — — 294 28,525
P 5962T Injection 5mg in 2mL — — 927 15,050
P 5963W Injection 50mg in 2mL — — 424 6,938
P 8851W Solution concentrate I.V. infusion 1000mg in 10mL — — 388 80,657
P 8852X Solution concentrate I.V. infusion 5000mg in 50mL — — 273 191,650
P 8863L Solution concentrate I.V. infusion 500mg in 20mL — — 114 7,676
L01BA04 PEMETREXED
P 5834C Powder for I.V. infusion 500mg (base) 2 — — 3,161 4,996,232
P 5835D Powder for I.V. infusion 100mg (base) 1 — — 1,742 1,117,477
P 9130M Powder for I.V. infusion 500mg (base) 2 — — 4,690 8,567,080
P 9131N Powder for I.V. infusion 100mg (base) 1 — — 5,531 11,007,713
L01BA03 RALTITREXED
P 8284B Powder for I.V. infusion 2mg — — 219 191,545
PURINE ANALOGUES
L01BB05 FLUDARABINE
P 5840J Powder for I.V. injection 50mg 5 — — 394 252,954
P 5841K Solution for I.V. injection 50mg in 2mL 5 — — 217 102,422
P 9184J Tablet 10mg 20 — — 845 884,616
P 9185K Powder for I.V. injection 50mg 5 — — 591 794,111
P 9207N Solution for I.V. injection 50mg in 2mL 5 — — 191 252,445
L01BB02 MERCAPTOPURINE
P 1598D Tablet 50mg — — 18,164 4,465,835
L01BB03 THIOGUANINE
P 1233X Tablet 40mg — — 745 192,058
PYRIMIDINE ANALOGUES
L01BC06 CAPECITABINE
P 8361C Tablet 150mg — — 1,578 207,826
P 8362D Tablet 500mg 120 — — 23,609 17,285,913
L01BC01 CYTARABINE
P 2884T Injection set containing 100mg and 5mL solvent — — 1,460 775,111
P 5918L Injection set containing 100mg and 5mL solvent — — 823 37,083
L01BC02 FLUOROURACIL
P 2528C Injection 500mg in 10mL — — 41,099 2,265,477
P 4222F Cream 50mg per g (5%) 20g — — 99,140 5,349,903
P 5872C Injection 1000mg in 20mL 5 — — 9,643 259,743
P 5935J Injection 500mg in 10mL — — 13,355 394,758
P 9005Y Injection 1000mg in 20mL 5 — — 11,818 601,538
L01BC05 GEMCITABINE
P 5843M Solution concentrate for I.V. infusion 200mg (base) in 20mL — — 186 27,154

L01 - ANTINEOPLASTIC AGENTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
ANTIMETABOLITES
P 5844N Solution concentrate for I.V. infusion 1000mg (base) in 100mL — — 692 223,733
P 5845P Solution concentrate for I.V. infusion 2gm (base) — — 968 423,158
P 5852B Solution concentrate for I.V. infusion 500mg (base) in 50mL 4 — — 204 33,774
P 5936K Powder for I.V. infusion 200mg (base) — — 4,077 533,214
P 5937L Powder for I.V. infusion 1gm (base) — — 6,806 2,279,802
P 8049P Powder for I.V. infusion 200mg (base) — — 5,053 2,111,132
P 8050Q Powder for I.V. infusion 1gm (base) — — 11,741 9,167,926
P 9401T Solution concentrate for I.V. infusion 200mg (base) in 20mL — — 947 599,863
P 9402W Solution concentrate for I.V. infusion 1000mg (base) in 100mL — — 1,260 1,064,379
P 9414L Solution concentrate for I.V. infusion 2gm (base) — — 2,018 2,285,750
P 9463C Solution concentrate for I.V. infusion 500mg (base) in 50mL 4 — — 671 384,919
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
VINCA ALKALOIDS AND ANALOGUES
L01CA01 VINBLASTINE SULPHATE
P 2199R Injection set containing 10mg and 10mL solvent — — 1,319 140,859
P 5989F Injection set containing 10mg and 10mL solvent — — 1,266 44,560
L01CA02 VINCRISTINE SULPHATE
P 2374Y Injection set containing 1mg and 1mL solvent — — 5,309 653,276
P 5991H Injection set containing 1mg and 1mL solvent — — 4,350 118,918
L01CA04 VINORELBINE
P 5992J Solution for I.V. infusion 10mg (base) in 1mL — — 364 86,453
P 5993K Solution for I.V. infusion 50mg (base) in 5mL — — 1,387 462,748
P 8280T Solution for I.V. infusion 10mg (base) in 1mL — — 624 620,460
P 8281W Solution for I.V. infusion 50mg (base) in 5mL — — 1,426 1,291,939
P 9009E Capsule 20mg (base) 20 — — 124 198,476
PODOPHYLLOTOXIN DERIVATIVES
L01CB01 ETOPOSIDE
P 1389D Capsule 100mg — — 474 166,355
P 1390E Solution for I.V. infusion 100mg in 5mL — — 3,266 537,302
P 1396L Capsule 50mg — — 620 251,867
P 5931E Solution for I.V. infusion 100mg in 5mL — — 852 76,743
P 5932F Powder for I.V. infusion 100mg (as phosphate) — — 4,605 350,864
P 5933G Powder for I.V. infusion 1g (as phosphate) — — 223 60,923
P 8120J Powder for I.V. infusion 100mg (as phosphate) — — 3,174 502,651
P 8515E Powder for I.V. infusion 1g (as phosphate) — — 1,912 631,544
P 9010F Capsule 30mg,16 — — 258 490,028
TAXANES
L01CD02 DOCETAXEL
P 5921P Injection set containing I.V. infusion 20mg — — 4,272 2,534,427
P 5922Q Injection set containing I.V. infusion 80mg — — 6,580 9,344,541
P 8071T Injection set containing I.V. infusion 20mg — — 10,678 16,645,066
P 8074Y Injection set containing I.V. infusion 80mg — — 13,336 29,370,447
P 9291B Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) — — 405 687,632

L01 - ANTINEOPLASTIC AGENTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01CD01 PACLITAXEL
P 3017T Solution for I.V. infusion 150mg in 25mL — — 5,193 11,113,051
P 3026G Solution for I.V. infusion 30mg in 5mL — — 5,937 7,415,081
P 5847R Solution for I.V. infusion 100mg (base) 1 — — 4,667 3,027,962
P 5973J Solution for I.V. infusion 30mg in 5mL — — 2,294 813,610
P 5974K Solution for I.V. infusion 100mg in 16.7mL — — 1,928 1,451,908
P 5975L Solution for I.V. infusion 150mg in 25mL — — 1,931 1,912,377
P 5976M Solution for I.V. infusion 300mg in 50mL — — 1,544 2,612,863
P 8018B Solution for I.V. infusion 100mg in 16.7mL — — 3,770 6,757,522
P 8360B Solution for I.V. infusion 300mg in 50mL — — 3,633 7,393,627
P 9415M Solution for I.V. infusion 100mg (base) 1 — — 5,432 10,319,829
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
ANTHRACYCLINES AND RELATED SUBSTANCES
L01DB01 DOXORUBICIN HYDROCHLORIDE
P 1336H Solution for I.V. or intravesical 10mg — — 694 25,674
P 1340M Solution for I.V. or intravesical 20mg — — 549 46,911
P 1342P Solution for I.V. or intravesical 50mg — — 8,595 1,090,952
P 5879K Solution for I.V. or intravesical 100mg in 50mL — — 3,069 348,070
P 5880L Solution for I.V. or intravesical 200mg in 100mL — — 383 55,982
P 5891C Solution for I.V. infusion 20mg in 10mL — — 908 839,168
P 5892D Suspn for IV infusion 50mg in 25mL — — 688 1,070,943
P 5925W Solution for I.V. or intravesical 10mg — — 580 10,371
P 5926X Solution for I.V. or intravesical 20mg — — 1,036 37,931
P 5927Y Solution for I.V. or intravesical 50mg — — 3,668 226,118
P 8569B Suspn for IV infusion 20mg in 10mL — — 2,091 4,074,069
P 8570C Suspn for IV infusion 50mg in 25mL — — 1,631 3,411,950
P 8827N Solution for I.V. or intravesical 100mg in 50mL — — 6,458 946,706
P 8828P Solution for I.V. or intravesical 200mg in 100mL — — 513 94,845
L01DB03 EPIRUBICIN HYDROCHLORIDE
P 1375J Solution for I.V. injection 10mg in 5mL 4 — — 389 61,144
P 1376K Solution for I.V. injection 20mg in 10mL 4 — — 183 75,960
P 1377L Solution for I.V. injection 50mg in 25mL 3 — — 5,263 4,612,981
P 5884Q Solution for injection 200mg in 100mL — — 840 686,854
P 5885R Solution for injection 100mg in 50mL 2 — — 1,612 926,886
P 5928B Solution for I.V. injection 10mg in 5mL 4 — — 442 37,562
P 5929C Solution for I.V. injection 20mg in 10mL 4 — — 440 76,963
P 5930D Solution for I.V. injection 50mg in 25mL 3 — — 1,689 890,516
P 8817C Solution for injection 100mg in 50mL 2 — — 2,643 2,220,622
P 8858F Solution for injection 200mg in 100mL — — 1,349 1,301,215
L01DB06 IDARUBICIN HYDROCHLORIDE
P 8531B Solution for I.V. injection 10mg in 10mL — — 165 327,653
L01DB07 MITOZANTRONE
P 1929M Injection 20mg in 10mL — — 1,082 215,272

L01 - ANTINEOPLASTIC AGENTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
P 1930N Injection 25mg in 12.5mL — — 757 180,448
P 1932Q Injection 10mg in 5mL — — 175 17,564
P 5965Y Injection 20mg in 10mL — — 284 45,642
P 5966B Injection 25mg in 12.5mL — — 179 36,128
OTHER CYTOTOXIC ANTIBIOTICS
L01DC01 BLEOMYCIN
P 2315W Injection 15,000 units (solvent required) — — 1,144 387,343
P 5903Q Injection 15,000 units (solvent required) — — 1,981 169,664
P 6896Y Injection 15,000 units 10mL and NS — — 127 32,969
OTHER ANTINEOPLASTIC AGENTS
PLATINUM COMPOUNDS
L01XA02 CARBOPLATIN
P 1160C Solution for I.V. injection 50mg in 5mL — — 1,933 110,378
P 1161D Solution for I.V. injection 150mg in 15mL — — 14,756 5,456,397
P 1162E Solution for I.V. injection 450mg in 45mL — — 8,068 1,952,583
P 5906W Solution for I.V. injection 50mg in 5mL — — 2,498 94,920
P 5907X Solution for I.V. injection 150mg in 15mL — — 6,582 980,926
P 5908Y Solution for I.V. injection 450mg in 45mL — — 6,054 869,712
L01XA01 CISPLATIN
P 2578Q I.V. injection 10mg in 10mL — — 184 3,537
P 2579R I.V. injection 50mg in 50mL — — 4,634 196,581
P 2580T I.V. injection 100mg in 100mL — — 11,315 722,815
P 5909B I.V. injection 10mg in 10mL — — 341 2,260
P 5910C I.V. injection 50mg in 50mL — — 2,076 37,046
P 5911D I.V. injection 100mg in 100mL — — 5,884 264,020
L01XA03 OXALIPLATIN
P 2310N Powder for I.V. infusion 200mg in 40mL — — 3,284 6,267,753
P 5877H Solution for I.V. infusion 50mg in 10mL — — 1,900 719,454
P 5878J Solution for I.V. infusion 100mg in 20mL — — 3,148 2,605,729
P 5994L Powder for I.V. infusion 50mg — — 1,397 506,444
P 5995M Powder for I.V. infusion 100mg — — 2,429 2,111,026
P 5999R Powder for I.V. infusion 200mg in 40mL — — 1,740 2,116,229
P 8539K Powder for I.V. infusion 50mg — — 6,245 6,865,600
P 8540L Powder for I.V. infusion 100mg — — 6,688 11,456,664
P 8847P Solution for I.V. infusion 50mg in 10mL — — 2,084 2,587,209
P 8848Q Solution for I.V. infusion 100mg in 20mL — — 2,680 4,760,730
MONOCLONAL ANTIBODIES
L01XC07 BEVACIZUMAB
P 5849W Soln for IV infusion 100mg/4mL — — 3,799 2,252,408
P 5850X Soln for IV infusion 400mg/16mL — — 4,645 8,627,520
P 9442Y Soln for IV infusion 100mg/4mL — — 8,942 14,856,435
P 9443B Soln for IV infusion 400mg/16mL — — 11,614 30,046,030
L01XC06 CETUXIMAB

L01 - ANTINEOPLASTIC AGENTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
P 5836E Solution for IV infusion 100mg in 20mL 1 — — 265 101,618
P 5837F Solution for IV infusion 500mg in 100mL 1 — — 207 358,050
P 5838G Solution for IV infusion 100mg in 20mL 1 — — 142 85,250
P 5839H Solution for IV infusion 500mg in 100mL 1 — — 210 358,050
P 9138Y Solution for IV infusion 100mg in 20mL 1 — — 189 313,156
P 9139B Solution for IV infusion 500mg in 100mL 1 — — 225 499,287
L01XC02 RITUXIMAB
P 5896H Solution for IV infusion 100mg\10mL — — 4,837 3,731,738
P 5897J Solution for IV infusion 500mg\50mL — — 4,119 9,368,916
P 5978P Solution for IV infusion 100mg\10mL — — 5,115 4,143,257
P 5979Q Solution for IV infusion 500mg\50mL — — 4,497 10,269,817
P 8293L Solution for IV infusion 100mg\10mL — — 12,594 16,149,208
P 8294M Solution for IV infusion 500mg\50mL — — 12,825 32,334,780
P 8665C Solution for IV infusion 100mg\10mL — — 10,842 13,880,404
P 8666D Solution for IV infusion 500mg\50mL — — 10,589 26,115,179
P 9611W Solution for IV infusion 500mg\50mL — — 1,328 6,060,981
L01XC03 TRASTUZUMAB
P 6497Y Powder for IV infusion 150mg — — 19,610 70,812,295
PROTEIN KINASE INHIBITORS
L01XE06 DASATINIB
P 2482P Tablet 50mg 60 — — 653 3,465,674
P 2485T Tablet 70mg 60 — — 211 1,349,441
P 9283N Tablet 50mg 60 — — 292 1,542,170
P 9341P Tablet 100mg 60 — — 111 584,691
L01XE03 ERLOTINIB
P 9166K Tablet 25mg (as hydrochloride) 30 — — 341 494,412
P 9167L Tablet 100mg (as hydrochloride) 30 — — 1,206 3,291,521
P 9168M Tablet 150mg (as hydrochloride) 30 — — 4,257 14,264,582
L01XE02 GEFITINIB
P 8769M Tablet 250mg 30 — — 347 1,350,057
L01XE01 IMATINIB
P 9111M Tablet 100mg (base) 60 — — 647 2,017,158
P 9112N Tablet 400mg (base) 30 — — 2,672 10,760,893
P 9113P Tablet 100mg (base) 60 — — 5,095 19,542,471
P 9114Q Tablet 400mg (base) 30 — — 12,435 52,620,710
P 9115R Tablet 100mg (base) 60 — — 497 2,244,185
P 9116T Tablet 400mg (base) 30 — — 719 3,540,385
P 9123E Tablet 100mg (base) 60 — — 235 782,741
P 9124F Tablet 400mg (base) 30 — — 207 827,889
P 9177B Tablet 400mg (base) 30 — — 171 669,593
L01XE07 LAPATINIB
P 9148L Tablet 250mg 140 — — 1,141 3,838,656
L01XE08 NILOTINIB

L01 - ANTINEOPLASTIC AGENTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
P 9171Q Capsule 200mg (as hydrochloride monohydrate) 112 — — 734 4,069,794
P 9285Q Capsule 200mg (as hydrochloride monohydrate) 112 — — 372 2,048,187
L01XE05 SORAFENIB
P 9380Q Tablet 200mg (as tosylate) 120 — — 1,255 8,078,581
L01XE04 SUNITINIB
P 9417P Capsule 12.5mg (as malate) 28 — — 174 322,372
P 9418Q Capsule 25mg (as malate) 28 — — 284 1,010,202
P 9419R Capsule 50mg (as malate) 28 — — 538 3,779,018
P 9420T Capsule 12.5mg (as malate) 28 — — 1,343 2,682,542
P 9421W Capsule 25mg (as malate) 28 — — 2,075 7,395,731
P 9422X Capsule 50mg (as malate) 28 — — 980 6,824,500
P 9489K Capsule 25mg (as malate) 28 — — 146 515,160
P 9490L Capsule 50mg (as malate) 28 — — 139 980,453
OTHER ANTINEOPLASTIC AGENTS
L01XX27 ARSENIC TRIOXIDE
P 5851Y Injection concentrate 10mg in 10mL 60 — — 267 219,253
L01XX32 BORTEZOMIB
P 9117W Powder for injection 3.5mg (solvent required) 4 — — 1,775 12,763,879
P 9118X Powder for injection 3.5mg (solvent required) 4 — — 110 784,416
L01XX05 HYDROXYUREA
P 3093T Capsule 500mg — — 35,565 2,741,700
L01XX19 IRINOTECAN
P 5833B I V injection 500mg in 25mL — — 780 1,137,566
P 5846Q I V injection 300mg in 15mL — — 851 884,126
P 5958N I V injection 40mg in 2mL — — 1,941 283,599
P 5959P I V injection 100mg in 5mL — — 3,784 2,258,288
P 8414W I V injection 40mg in 2mL — — 2,357 1,343,856
P 8415X I V injection 100mg in 5mL — — 5,378 6,699,301
P 9119Y I V injection 500mg in 25mL — — 1,165 2,099,539
P 9410G I V injection 300mg in 15mL — — 4,091 4,679,665
L01XX17 TOPOTECAN
P 5985B Powder for I.V. infusion 4mg (base) — — 126 105,732
P 8199M Powder for I.V. infusion 4mg (base) — — 260 504,201

L02 - ENDOCRINE THERAPY

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
HORMONES AND RELATED AGENTS
PROGESTOGENS
L02AB02 MEDROXYPROGESTERONE
P 2316X Tablet 200mg 1000.00 MG 1,487 155,067
P 2725K Tablet 100mg 1000.00 MG 1,940 179,555
P 2727M Tablet 250mg 1000.00 MG 195 25,214
P 2728N Tablet 500mg 1000.00 MG 686 88,616
L02AB01 MEGESTROL
P 2734X Tablet 160mg 160.00 MG 1,407 109,593
GONADOTROPHIN RELEASING HORMONE ANALOGUES
L02AE03 GOSERELIN
P 1454M Subcutaneous implant 3.6mg 0.13 MG 20,621 6,854,976
P 8093Y Subcutaneous implant 10.8mg (base) in prefilled injection syringe 0.13 MG 46,808 51,892,030
P 9064C Subcutaneous implant 3.6mg (base) in prefilled injection syringe and 28 tabs 50mg 0.13 MG 413 199,157
P 9065D Subcutaneous implant 10.8mg (base) in prefilled injection syringe and 28 tabs 50mg 0.13 MG 671 839,912
P 9066E Subcutaneous implant 10.8mg (base) in prefilled injection syringe and 84 tabs 50mg 0.13 MG 3,106 4,785,308
L02AE02 LEUPRORELIN ACETATE
A 14727 Injection 5mg 0.13 MG 228 —
P 8707G Suspn subcutaneous inj (mod rel) 7.5mg inj set 0.13 MG 829 348,113
P 8708H Suspn subcutaneous inj (mod rel) 22.5mg inj set 0.13 MG 4,366 4,839,221
P 8709J Suspn subcutaneous inj (mod rel) 30mg inj set 0.13 MG 1,058 1,535,748
P 8859G Suspn subcutaneous inj (mod rel) 45mg inj set 0.13 MG 3,374 7,181,313
P 8875D I.M. injection (modified release) 7.5mg diluent 0.13 MG 3,419 1,436,338
P 8876E I.M. injection (modified release) 22.5mg diluent 0.13 MG 13,338 14,786,161
P 8877F I.M. injection (modified release) 30mg diluent 0.13 MG 9,340 13,557,874
HORMONE ANTAGONISTS AND RELATED AGENTS
ANTI-ESTROGENS
L02BA01 TAMOXIFEN
P 2109B Tablet 10mg (base) 60 20.00 MG 2,300 89,041
P 2110C Tablet 20mg (base) 60 20.00 MG 120,076 7,189,988
L02BA02 TOREMIFENE
P 8216K Tablet 60mg (base) 60.00 MG 1,677 118,984
ANTI-ANDROGENS
L02BB03 BICALUTAMIDE
P 8094B Tablet 50mg 50.00 MG 36,535 6,244,366
L02BB01 FLUTAMIDE
P 1417N Tablet 250mg 750.00 MG 2,393 496,602
L02BB02 NILUTAMIDE
P 8131Y Tablet 150mg 30.00 MG 4,774 1,147,270
ENZYME INHIBITORS
L02BG03 ANASTROZOLE
P 8179L Tablet 1mg 1.00 MG 215,977 38,882,707
L02BG06 EXEMESTANE
P 8506Q Tablet 25mg 30 25.00 MG 22,525 4,053,798

L02 - ENDOCRINE THERAPY

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
HORMONE ANTAGONISTS AND RELATED AGENTS
L02BG04 LETROZOLE
P 8245Y Tablet 2.5mg 2.50 MG 127,812 23,009,391

L03 - IMMUNOSTIMULANTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSTIMULANTS
CYTOKINES AND IMMUNOMODULATORS
COLONY STIMULATING FACTORS
L03AA02 FILGRASTIM
P 6126K Injection 300ug in 1mL 20 0.35 MG 176 323,325
P 6291D Injection 300ug in 0.5mL 20 0.35 MG 1,988 3,910,656
P 6292E Injection 480ug in 0.5mL 20 0.35 MG 936 4,000,422
L03AA13 PEGFILGRASTIM
P 6363X Injection 6mg in 0.6mL single use syringe 0.30 MG 15,884 33,300,663
INTERFERONS
L03AB07 INTERFERON BETA-1a
P 8289G Inj. set 1 vial powder dose 30ug (6,000,000iu) 4.30 UG 2,533 2,671,012
P 8403G Injection 44ug (12,000,000iu) in 0.5mL single syringe 4.30 UG 17,009 17,964,547
P 8805K Injection 30ug (6,000,000iu) in 0.5mL single syringe 4.30 UG 19,410 20,514,049
P 9332E Solution for injection 132ug in 1.5mL multidose cartridge 4 4.30 UG 2,234 2,478,364
L03AB08 INTERFERON BETA-1b
P 8101J Injection set 1 vial powder dose 8,000,000iu 4.00 ME 32,332 38,145,142
L03AB04 INTERFERON-ALFA-2a
P 8180M Solution for injection 3,000,000iu in 0.5mL 15 2.00 ME 1,353 745,476
P 8181N Solution for injection 3,000,000iu in 0.5mL 15 2.00 ME 221 129,354
P 8551C Injection 45,000,000iu in 0.5mL syringe 5 2.00 ME 132 73,081
L03AB05 INTERFERON-ALFA-2b
P 8348J Solution for injection 18,000,000iu in 1.2mL multi-dose pen 3 2.00 ME 341 207,707
L03AB11 PEGINTERFERON ALFA-2a
P 6449K Prefilled syringe 180ug/0.5mL 8 26.00 UG 301 446,671
L03AB61 RIBAVIRIN and PEGINTERFERON ALFA-2a
P 6394M 112 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2 — — 407 697,041
P 6395N 140 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2 — — 837 1,512,919
P 6396P 168 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2 — — 1,156 2,236,288
L03AB60 RIBAVIRIN and PEGINTERFERON ALFA-2b
P 6405D 112 ribavirin 200mg/4 single use injection pens 2 — — 325 536,062
P 6407F 140 ribavirin 200mg/4 single use injection pens 2 — — 504 901,473
P 6410J 168 ribavirin 200mg/4 single use injection pens 2 — — 204 504,511
OTHER IMMUNOSTIMULANTS
L03AX03 BCG VACCINE
P 1131M Vial powder for intravesical admin. 5x10^8 CFU — — 1,620 886,414
P 1140B Injection set 1 vial Powder — — 1,551 577,089
P 5901N Injection set 1 vial Powder — — 789 173,610
P 5902P Ampoule containing powder 5x10^8 CFU — — 217 49,674
L03AX13 GLATIRAMER ACETATE
P 8726G Inj 20mg in 1mL single dose prefilled syringe 20.00 MG 25,194 27,524,049

L04 - IMMUNOSUPPRESSANTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
SELECTIVE IMMUNOSUPPRESSANTS
L04AA24 ABATACEPT
P 9621J Powder for I.V. infusion 250mg 27.00 MG 6,064 9,567,624
L04AA18 EVEROLIMUS
P 8840G Tablet 0.25mg 60 1.50 MG 215 65,647
P 8841H Tablet 0.5mg 60 1.50 MG 687 501,188
P 8842J Tablet 0.75mg 120 1.50 MG 411 679,874
L04AA13 LEFLUNOMIDE
P 8374R Tablet 10mg 30 20.00 MG 53,186 4,977,981
P 8375T Tablet 20mg 30 20.00 MG 127,068 17,597,031
L04AA06 MYCOPHENOLIC ACID
P 6208R Capsule 250mg 600 2.00 GM 263 90,894
P 6209T Tablet 500mg 300 2.00 GM 1,367 915,180
P 6370G Tablet (enteric coated) 360mg 240 2.00 GM 234 136,739
P 8649F Capsule 250mg 300 2.00 GM 1,560 919,955
P 8650G Capsule 500mg 150 2.00 GM 9,195 5,871,181
P 8652J Tablet (enteric coated) 180mg 120 2.00 GM 315 86,102
P 8653K Tablet (enteric coated) 360mg 120 2.00 GM 1,496 751,655
L04AA23 NATALIZUMAB
P 9624M Sol.concentrate for I.V. infusion 300mg in 15mL 10.00 MG 3,948 8,278,918
L04AA10 SIROLIMUS
P 8724E Tablet 1mg 100 3.00 MG 470 400,418
P 8833X Tablet 2mg 100 3.00 MG 233 385,362
TUMOR NECROSIS FACTOR ALPHA INHIBITORS
L04AB04 ADALIMUMAB
P 8737W Injection 40mg in 0.8mL prefilled syringe 2.90 MG 1,128 1,997,650
P 8741C Injection 40mg in 0.8mL prefilled syringe 2.90 MG 12,788 22,682,273
P 9033K Injection 40mg in 0.8mL prefilled syringe 2.90 MG 282 500,028
P 9034L Injection 40mg in 0.8mL prefilled syringe 2.90 MG 2,444 4,334,653
P 9077R Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 348 616,245
P 9078T Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 2,484 4,403,939
P 9099X Injection 40mg in 0.8mL prefilled syringe 2.90 MG 4,147 7,350,011
P 9100Y Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 27,381 48,571,780
P 9101B Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 1,526 2,707,783
P 9102C Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 7,807 13,850,045
P 9103D Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 1,553 2,751,172
P 9104E Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 8,773 15,556,186
P 9186L Injection 40mg in 0.8mL prefilled syringe 6 2.90 MG 173 905,161
P 9187M Injection 40mg in 0.8mL prefilled pen 6 2.90 MG 488 2,482,802
P 9188N Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 561 995,960
P 9189P Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 3,591 6,369,935
P 9190Q Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 1,454 2,583,075
P 9191R Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 8,040 14,272,072

L04 - IMMUNOSUPPRESSANTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
P 9425C Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 869 1,538,663
P 9426D Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 1,023 1,813,353
P 9427E Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 3,044 5,398,488
P 9428F Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 3,440 6,104,097
L04AB05 CERTOLIZUMAB PEGOL
P 3425G Injection 200mg in 1mL single use prefilled syringe 1 14.00 MG 371 634,546
L04AB01 ETANERCEPT
P 6367D Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 1,487 2,500,848
P 8637N Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 165 301,907
P 8638P Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 3,128 5,743,028
P 8779C Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 830 1,507,983
P 9036N Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 381 694,962
P 9085E Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 706 1,251,353
P 9086F Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 5,353 9,515,675
P 9087G Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 279 495,050
P 9088H Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 3,340 5,926,309
P 9089J Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 1,137 2,022,801
P 9090K Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 20,231 35,935,942
P 9091L Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 212 381,471
P 9429G Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 171 305,437
P 9431J Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 3,398 6,036,088
P 9455P Injection 50mg in 1mL single use auto injector, 4 7.00 MG 713 1,270,449
P 9456Q Injection 50mg in 1mL single use auto injector, 4 7.00 MG 3,815 6,811,875
P 9457R Injection 50mg in 1mL single use auto injector, 4 7.00 MG 858 1,522,411
P 9458T Injection 50mg in 1mL single use auto injector, 4 7.00 MG 2,922 5,184,977
P 9459W Injection 50mg in 1mL single use auto injector, 4 7.00 MG 3,631 6,458,710
P 9460X Injection 50mg in 1mL single use auto injector, 4 7.00 MG 15,530 27,582,094
P 9461Y Injection 50mg in 1mL single use auto injector, 4 7.00 MG 217 385,185
P 9462B Injection 50mg in 1mL single use auto injector, 4 7.00 MG 784 1,401,889
P 9615C Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 310 521,292
P 9641K Injection 50mg in 1mL single use auto injector, 4 7.00 MG 126 210,952
L04AB06 GOLIMUMAB
P 3426H Injection 50mg in 0.5mL single use prefilled syringe 1 1.66 MG 260 462,095
P 3427J Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 960 1,706,216
P 3429L Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 545 967,572
P 3431N Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 346 614,979
P 3433Q Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 178 316,358
P 3434R Injection 50mg in 0.5mL single use prefilled syringe 1 1.66 MG 116 206,146
P 3435T Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 451 801,649
P 3437X Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 218 387,449
L04AB02 INFLIXIMAB
P 6397Q Powder for I.V. infusion 100mg 1 3.75 MG 1,515 3,534,623
P 6448J Powder for I.V. infusion 100mg 1 3.75 MG 3,552 12,423,552

L04 - IMMUNOSUPPRESSANTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
P 6496X Powder for I.V. infusion 100mg 1 3.75 MG 839 3,131,130
P 9612X Powder for I.V. infusion 100mg 1 3.75 MG 441 1,117,610
P 9613Y Powder for I.V. infusion 100mg 1 3.75 MG 3,968 12,639,373
P 9617E Powder for I.V. infusion 100mg 1 3.75 MG 1,332 4,984,221
P 9674E Powder for I.V. infusion 100mg 1 3.75 MG 127 417,275
INTERLEUKIN INHIBITORS
L04AC03 ANAKINRA
P 8774T Injection 100mg in 0.67mL pre-filled syringe 28 0.10 GM 173 236,092
L04AC07 TOCILIZUMAB
P 9671B Concentrate for injection 80mg in 4mL 1 20.00 MG 1,416 582,453
P 9672C Concentrate for injection 200mg in 10mL 1 20.00 MG 669 392,521
P 9673D Concentrate for injection 400mg in 20mL 1 20.00 MG 1,796 2,196,746
L04AC05 USTEKINUMAB
P 9304Q Injection 45mg in 0.5mL 0.54 MG 1,081 6,969,368
P 9305R Injection 45mg in 0.5mL 0.54 MG 263 1,789,144
CALCINEURIN INHIBITORS
L04AD01 CYCLOSPORIN
P 6232B Capsule 10mg (with microemulsion pre-concentrate) 120 0.25 GM 327 27,558
P 6352H Capsule 25mg 120 0.25 GM 1,130 217,405
P 6353J Capsule 50mg 120 0.25 GM 1,476 382,554
P 6354K Capsule 100mg 120 0.25 GM 1,693 865,750
P 8657P Capsule 10mg 120 0.25 GM 1,209 132,737
P 8658Q Capsule 25mg 60 0.25 GM 9,769 1,327,788
P 8659R Capsule 50mg 60 0.25 GM 13,192 2,865,097
P 8660T Capsule 100mg 60 0.25 GM 12,571 5,449,404
P 8661W Oral liquid 100mg per mL 0.25 GM 336 212,627
L04AD02 TACROLIMUS
P 6216E Capsule 1mg 200 5.00 MG 953 749,418
P 6328C Capsule 500ug 200 5.00 MG 226 52,156
P 8646C Capsule 500ug 100 5.00 MG 3,364 762,975
P 8647D Capsule 1mg 100 5.00 MG 10,377 6,258,369
P 8648E Capsule 5mg 100 5.00 MG 559 905,511
OTHER IMMUNOSUPPRESSANTS
L04AX01 AZATHIOPRINE
P 2687K Tablet 50mg 0.15 GM 136,999 7,837,044
P 2688L Tablet 25mg 0.15 GM 16,199 598,275
L04AX04 LENALIDOMIDE
P 9642L Capsule 5mg 21 10.00 MG 184 1,015,391
P 9643M Capsule 10mg 21 10.00 MG 542 3,176,251
P 9644N Capsule 15mg 21 10.00 MG 757 4,970,586
P 9645P Capsule 25mg 21 10.00 MG 1,812 12,612,259
L04AX02 THALIDOMIDE
P 6469L Capsules 50mg 112 0.10 GM 3,328 3,606,640
Last updated
1 January 2010